Research in Progress Seminars

Open to Members Only

2021 RIP Schedule

2020 RIP Schedule

Date Speaker  Affiliation TitleModerator 

Jan 10, 2020

Dr. Kaarina Kowalec

University of Manitoba

Precision medicine approaches to pharmacotherapy in multiple sclerosis and schizophrenia

Dr. Sook Wah Yee

Feb 14, 2020

Dr. Bani Tamraz

University of California San Francisco

Pharmacogenomics of atazanavir and efavirenz under conditions of actual use in women living with HIV

Dr. Sook Wah Yee

Mar 6, 2020

Dr. Tien Truong

University of Chicago

Implementation of Point-of-Care Pharmacogenomics Decision Support in Perioperative Care

Dr. C. William Heise

Apr 10, 2020

Dr. Rowan AlEjielat

University of Petra

An evaluation of the knowledge, opinions, expectations and concerns toward pharmacogenomics among Jordanian pharmacists

Dr. Bani Tamraz

May 8, 2020

Dr. Chiara Fabbri

King's College London

Whole exome sequencing and genome-wide genotyping in treatment-resistant depression: predictive models and application to drug repositioning

Michael Marschler
Jun 12, 2020
Dr. Chris Gignoux
University of Colorado
Genomic Approaches to Population Health in Multi-Ethnic Hospital SystemsAndrew Monte

2018 RIPS Speaker Schedule






Jan 12, 2018





Feb 9, 2018

Dr. Stephanie Huang 

University of Minnesota

Leverage high throughput  data for pharmacogenomic discovery and drug repurposing

Jun Yang

 Mar 9, 2018   



Apr 13, 2018

Dr. Eileen Dolan 

University of Chicago  

Pharmacogenomics of Anticancer Agent Toxicity: Challenges and Opportunities 

Sook Wah Yee

May 11, 2018 

Dr. Hae Kyung Im

University of Chicago 

What can imputed transcriptome tell us about disease effector genes

Nancy Cox

Jun 8, 2018





Jul 13, 2018

Sisi Qin 

Mayo Clinic

TSPYL Family Regulates CYP17A1 and CYP3A4 Expression:
Potential Mechanism Contributing to Abiraterone Response in Castration-Resistant Prostate Cancer Patients  

Liewei Wang 

Aug 10, 2018

Dr. Wylie Burke and Dr. Kenneth Thummel 

University of Washington

​Inclusion in Pharmacogenomic Research: Scientific, Ethical and Policy Implications

Dr. Wylie Burke and Dr. Kenneth Thummel 

Sep 14, 2018

Dr. Jason Karnes 

University of Arizona

​Pharmacogenomics of Vasodilator Response In Pulmonary Arterial Hypertension

Ankit Desai

Oct 12, 2018 

​Dr. Nihal El Rouby

University of Florida

Pharmacogenetics Testing: Evidence Supporting Preemptive Genotyping for the seminar

Larisa Cavallari ​

Nov 9, 2018

Dr. John Witte and Dr. Sara Rashkin

University of California, San Francisco 

A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer

Dr. John Witte and Dr. Sara Rashkin

Dec 14, 2018

Dr. Frederic Rahbori

Dr. Hansjörg Rothe

Emory University

Klinikum Coburg

New genetic discoveries in Autosomal Dominant Polycystic Kidney Disease: The fruits of HALT-PKD and CRISP studies

Utilizing mendelian randomization to mimic long-term SGLT2 blocker and/or calcimimetic therapy in ADPKD

Arlene Chapman

2016 RIPS Speaker Schedule






Jan 15, 2016

Dr. Kelly Caudle


The Clinical Pharmacogenetics Implementation Consortium (CPIC) Update and Term Standardization Project

Dr. Stuart Scott

Feb 12, 2016

Beth Percha


Learning the structure of biomedical relationships from unstructured text

Dr. Nigam Shah

Mar 11, 2016   


Apr 8, 2016

Dr. Jun Yang

St. Jude Children's Research Hospital

NUDT15-related thiopurine toxicity: from molecular mechanisms to clinical implication

Dr. Deanna Kroetz

May 13, 2016 

Dr. Liewei Wang 

Mayo Clinic

PGx of breast cancer endocrine therapy

Dr. Vidya Chidambaran

Jun 10, 2016

Dr. Peter O’Donnell

University of Chicago

Precision Medicine Implementation at The University of Chicago – Adoption and Lessons from The 1200 Patients Project

Dr. Mary Relling

Jul 8, 2016

Dr. Eileen Dolan

University of Chicago

Pharmacogenomics of Anticancer Agent Toxicity: Clinical GWAS and Preclinical Models

Dr. Jun Yang

Aug 12, 2016

Dr. Seth Karol

St. Jude Children's Research Hospital

Germline genetics of relapse in high-risk pediatric acute lymphoblastic leukemia

Dr. Sook Wah Yee

Sep 9, 2016

Dr. Toni Pollin

University of Maryland

Identifying Diabetes Subtypes Leads to Precision Medicine

Dr. Rochelle Naylor​​​​

Oct 14, 2016 

Dr. Naohiro Terada

University of Florida

Stem Cell Research in The Era of Personal Genomics

Dr. Marisa Wong Medina

Nov 18, 2016

Dr. Michael Pacanowski and Dr. Rodney Rouse

U.S. Food and Drug Administration

FDA’s Biomarker Qualification Program and MicroRNA Biomarkers of Acute Pancreatic Injury

Dr. Mark Dunnenberger

Dec 9, 2016

Dr. Mohamed Shahin

University of Florida

Pharmacometabolomics Complements Pharmacogenomics and Reveals Novel Signatures Associated with the Blood Pressure Response to Thiazide Diuretics

Dr. Rhonda Copper-DeHoff​

2019 RIPS Speaker Schedule

 Date Speaker 


Title Moderator

Jan 11, 2019

Cancelled  -  - -

Feb 8, 2019

Dr. D. Max Smith & Dr. Cameron Thomas

MedStar Health and University of Florida

A Tale of Two Pains: CYP2D6-guided Pain Management

Dr. Larisa Cavallari

Mar 8, 2019

Carlos Díaz-Tufinio

National Institute of Genomic Medicine, Mexico

Pharmacogenetics and comparative bioavailability study in Mexican population applied to pharmacokinetic variables assessment

Dr. Bernard Esquivel

Apr 12, 2019

Dr. Haojie Zhu

University of Michigan

Integrating proteomics into pharmacogenomics research

Dr. Assaf Gottlieb

May 10, 2019

Dr. Jun Yang

St. Jude Children's Research Hospital

High Throughput Functional Characterization of Pharmacogenetic Variants in NUDT15

Dr. Jennifer Hockings

Jun 14, 2019

Dr. C. William Heise

University of Arizona

Convincing the Doubters: The Phoenix Approach to Implementing Pharmacogenomics and Proving Health Outcome Benefits in Disseminated Clinical Partners

Dr. Laura Ramsey

Jul 12, 2019

Dr. Kelly Caudle

St. Jude Children's Research Hospital

​Updates from the Clinical Pharmacogenetics Implementation Consortium

Dr. Bernard Esquivel

Aug 9, 2019

Melissa Chiasson

University of Washington

​Interpreting variation in pharmacogenes VKOR and CYP2C9 using multiplex assays

Dr. Allan Rettie

Sep 13, 2019

Dr. Danxin Wang

University of Florida

Role of unliganded estrogen receptor alpha in cytochrome P450 drug metabolizing enzymes gene expression

Dr. Wolfgang Sadee

Oct 11, 2019

Dr. Aritro Nath

City of Hope

Comprehensive pharmacogenomic landscape of lncRNAs identifies EGFR-AS1 and MIR205HG as novel determinants of anti-EGFR therapeutic response in lung cancer

Dr. Carlos Díaz-Tufinio

Nov 8, 2019

Dr. Christina Aquilante & Dr. Elizabeth Kudron

University of Colorado

Clinical implementation of pharmacogenomics via a health system-wide research biobank: the University of Colorado experience

Dr. Umamaheswaran Gurusamy

Dec 13, 2019

Ahmed El-Boraie

University of Toronto

Genetic risk scores for CYP2A6 across ancestries: application to clinical trial data

Dr. Junmei Cairns

2017 RIPS Speaker Schedule






Jan 13, 2017


Feb 10, 2017

Dr. Michelle Whirl-Carrillo


Evaluating Literature Evidence Supporting PGx Associations Using PharmGKB and CPIC Methods

Dr. Stuart Scott

Mar 10, 2017

 Dr. Ming-Fen Ho

Mayo Clinic

TCL1A to NF-kB Aromatase Inhibitor GWAS to Inflammatory Mediators

Dr. Liewei Wang

Apr 14, 2017

 Dr. Andrew Monte

University of Colorado Denver

CYP2D6: The Hub of a Systems Biology Model

Dr. Folefac Aminkeng

May 12, 2017

Dr. Esteban Burchard


Leveraging the Genetics of Racially Mixed Children to Advance Precision Medicine

Dr. Irma Aguilar-Delfin

Jun 9, 2017

Dr. Katie White

Vanderbilt University

Personalizing approaches to severe immunologically-mediated adverse drug reactions: Characterizing drug and tissue specific immune signatures

Dr. David Koelle

Jul 21, 2017





Aug11, 2017

Dr. Beth Theusch

Children's Hospital Oakland Research Institute

Transcriptomics and genomics of statin response

Dr. Mathura Shanmugasundaram

Sep 15, 2017 
Date Change

Victoria Marshe

University of Toronto

Genomic analyses in late life depression

Laura Parham

Oct 27, 2017
Date Change

Dr. Minoli Perera

Northwestern University

A GWAS of primary nonresponse to TNF-alpha biologics in Inflammatory Bowel disease

Dr. Sook Wah Yee

Nov 17, 2017
Date Change

Dr. Balmiki Ray

Assurex Health

Informing Genomics by other “omics”: Implications in Precision Medicine for Neuropsychiatric Disorders

Dr. Daniel Mueller

Dec 8, 2017

Steven Lee and Rachel Dalton

University of Washington

Stargazer: a software tool for calling star alleles from next-generation sequencing data using CYP2D6 as a model

Dr. Erica Woodahl

2015 RIPS Speaker Schedule

PGRN 3 began in July of 2015. For a history of the PGRN please read What is PGRN?






August 14, 2015

Dr. Seth Karol


Pharmacogenetics of Osteonecrosis

Dr. Kathy Giacomini

September 18, 2015

Dr. Dara Torgerson


Rare Variants and Bronchodilator Drug Response in Multi-Ethnic Populations

Dr. Kelan Tantisira

October 16, 2015

Dr. Marylyn Ritchie


Using genomics and electronic health records for precision medicine - thinking about the future

Dr. Scott Weiss

November 13, 2015

Dr. Wei-Qi Wei


Developing Computable Medication Indication Resource to Optimize Phenotyping

Dr. James Hoffman

December 11, 2015

Dr. Douglas Fowler


Massively parallel measurement of the impact of mutations in proteins

Dr. Maitreya Dunham​

Copyright © 2020 the Pharmacogenomics Global Research Network. All Rights Reserved.

PGRN is a 501(c)3 Non-Profit Association

Follow PGRN
on Social Media

Become a Member

PGRN logo
Membership dues are vital to continue the mission and work of the PGRN. Join your colleagues today and suport the work of PGRN. 
Powered by Wild Apricot Membership Software